
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on March 23, 2023
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
4,268 cr
Turnover Ratio
38.42%
Expense Ratio
1.26%
Exit Load
1.00%
if redeemed within
Returns
- 1M: -0.76%
- 1Y: -6.13%
- 3M: -6.05%
- 3Y: 28.27%
- 6M: -2.11%
- 5Y: 16.20%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
240.197 | -0.89% | 1,632 cr | 1.09% | - |
Other plans of Nippon India Pharma